TEM — Tempus AI Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Key stats#
Price data
- Price
- $75.61
- YTD price return
- +28.04%
- YTD total return
- +28.04%
- Market cap
- 13.8B
- Enterprise value
- 14.6B
- Shares outstanding
- 182.4M
- 52W low
- $40.77
- 52W high
- $89.09
- From 52W high
- -15.13%
- From 52W low
- +85.45%
- 52W range
- 72%$40.77–$89.09
Volume
- Rel volume
- 0.86×
- 30D volume
- 6.9M
- 30D $ vol
- 513.3M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- −$17.6M
- Insider net 3M
- −$90.5M
- Insider net 1Y
- −$167.2M
Form 4 transactions by trade date, as filed; latest on file 2026-10-27.
Fundamentals
- Sales (ttm)
- 1.5B
- Sales/share
- $8.27
- EPS (ttm)
- -$1.05
- FCF (ttm)
- -150.6M
- FCF/share
- -$0.83
- Book value/share
- $2.74
- Net margin
- -12.54%
- ROE
- -37.83%
- ROA
- -7.72%
- Debt / equity
- 2.70×
- Current ratio
- 2.61
Growth (CAGR, ttm) · 10Y
- Sales
- +36.59%+46.15%n/an/a
- Shares
- +2.53%+42.30%n/an/a
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- +33.22%-0.48%n/an/a
- Book value/share
- -3.89%n/an/an/a
- Dividend/share
- -47.11%n/an/an/a
- Price
- -10.52%+30.18%n/an/a
- Total return
- -10.52%+30.18%n/an/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -72.0×
- Fwd P/E
- -1713.9×
- P/S (ttm)
- 9.1×
- P/B (mrq)
- 27.6×
- EV/Sales (ttm)
- 9.7×
- FCF yield (ttm)
- -1.09%
- Buyback yield (realized, 1y)
- -2.53%
- Shareholder yield (realized, 1y)
- -2.53%
- Buyback yield (cash, ttm)
- 0.02%
- Shareholder yield (cash, ttm)
- 0.02%
Performance · price returntotal return · as of 2026-11-04#
Fundamentals#
Operating income
YoY n/mEPS (diluted)
YoY n/mFree cash flow
YoY n/mTTM: operating cash flow −$108.4M, capex −$42.3M
Q3 2026: operating cash flow $9.2M, capex −$14.8M
Shares (diluted)
YoY +3.6%Dividend per share
No quarters filed for this figure.
About Tempus AI#
Tempus AI Inc Class A Common Stock is the equity of Tempus AI, a healthcare technology company focused on applying artificial intelligence and machine learning to precision medicine. The company develops AI-enabled solutions that help physicians use clinical and molecular data to support more personalized care, while also providing tools and services that assist life-sciences customers with research, diagnostics, and therapeutic development. Its current business is organized around genomics, data, and artificial intelligence applications, with products spanning next-generation sequencing, molecular profiling, clinical decision support, and software-based diagnostic tools. Tempus AI serves healthcare providers, researchers, and pharmaceutical and biotechnology companies across oncology and other clinical areas, including cardiology, neuropsychiatry, infectious disease, and radiology. The stock represents ownership in a company positioned at the intersection of healthcare, data analytics, and diagnostic innovation.
Chicago, IL·3,800 employees·Health Information Services·tempus.com·As of Oct 30, 2026
Recent filings#
- Nov 2Earnings · Earnings release — EPS −$0.21 vs −$0.32 est. (+34.4%); revenue $411.5M (+23% y/y) 8.7%
- Aug 18Insider sale · LEFKOFSKY ERIC P (CEO and Chairman · Director · 10% owner) sold 132,591 Class A shares for $6.6M at $49.61
- Aug 18Insider sale · Fukushima Ryan (CEO, Data) sold 41,095 Class A shares for $2.0M at $49.61
- Aug 18Insider sale · Bartolucci Ryan M (Chief Accounting Officer) sold 6,175 Class A shares for $306K at $49.61
- Jul 30Earnings · Earnings release — EPS −$0.35 vs −$0.41 est. (+14.6%); revenue $382.5M (+22% y/y) 0.9%
ETFs holding TEM#
21 of the 193 ETFs ChartRow carries live hold TEM. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).
| Fund | Name | Filed weight |
|---|---|---|
| ARKK | ARK Innovation ETF | 4.9% |
| IBB | iShares Biotechnology ETF | 0.5% |
| VBK | Vanguard Small-Cap Growth ETF | 0.2% |
| IWP | iShares Russell Mid-Cap Growth ETF | 0.2% |
| VHT | Vanguard Health Care ETF | 0.1% |
| VB | Vanguard Small-Cap ETF | 0.1% |
| VXF | Vanguard Extended Market ETF | 0.1% |
| IWR | iShares Russell Midcap ETF | 0.0% |
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +24.07% | +0.61% |
| JNJ | Johnson & Johnson | +7.92% | +3.81% |
| ABBV | AbbVie Inc. | +12.18% | +3.09% |
| MRK | Merck & Co. Inc. | +4.20% | +3.93% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +10.08% | +1.22% |
| NVS | Novartis AG | +17.01% | +3.59% |
| TMO | Thermo Fisher Scientific Inc. | +7.84% | +1.12% |
| AMGN | Amgen Inc. | +18.69% | +3.71% |
